Patent directory · USPTO A61K / A61P
Patents matching “Orionis Biosciences, Inc”
20 pharma patents match "Orionis Biosciences, Inc" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 20 pharmaceutical patents matching "Orionis Biosciences, Inc" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12410225
Modulation of dendritic cell lineages
granted -
US 12364753
CD8 binding agents
granted -
US 12351614
CLEC9A-based chimeric protein complexes
granted -
US 12351633
PD-1 and PD-L1 binding agents
granted -
US 12091463
Clec9A binding agents comprising a recombinant heavy-chain only antibody (VHH)
granted -
US 12084497
SIRP1α targeted chimeric proteins and uses thereof
granted -
US 11896643
Fibroblast binding agents and use thereof
granted -
US 11753463
Therapeutic targeting of non-cellular structures
granted -
US 11702477
Bi-functional chimeric proteins and uses thereof
granted -
US 11661455
Chimeric protein comprising an interferon alpha 2mutant and a PD-L1 binding moiety
granted -
US 11566072
CD8 binding agents
granted -
US 11498966
PD-1 and PD-L1 binding agents
granted -
US 11440943
Therapeutic interferon alpha 1 proteins
granted -
US 11384154
Targeted chimeric proteins and uses thereof
granted -
US 11236141
Targeted mutant interferon-beta and uses thereof
granted -
US 11236166
CD8 binding agents
granted -
US 11084859
Targeted mutant interferon-gamma and uses thereof
granted -
US 11001631
Clec9A binding agents
granted -
US 10988538
Bispecific signaling agents and uses thereof
granted -
US 10906985
Targeted engineered interferon and uses thereof
granted